Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Stroke. 2010 Oct;41(10 Suppl):S135–S138. doi: 10.1161/STROKEAHA.110.595272

Figure 3.

Figure 3

Brain capillary amyloid deposition and associated pathology in Tg-SwDI/NOS2−/− mice and human CAA Type 1. Brain sections from twelve months old Tg-SwDI/NOS2−/− mice (A,B) and a case of human CAA Type 1 (D,E) were immunolabeled for collagen Type IV to identify capillaries (red) and stained with thioflavin S (green) to identify fibrillar amyloid (A,D) or immunolabeled for MHC II (brown) to identify activated microglia (B,E). Scale bars = 50 µm. Similarly, brain sections from twelve months old Tg-SwDI/NOS2−/− mice (C) and a case of human CAA Type 1 (F) were immunolabeled for hyperphosphorylated tau using AT8 antibody (red) and stained with thioflavin S (green) to identify fibrillar amyloid. Scale bars = 20 µm.

HHS Vulnerability Disclosure